May 2017

Salus University Awarded Funds for Patient Centered Medical Home

Salus University Awarded Funds for Patient Centered Medical Home

The Eye Institute (TEI) of Salus University/PCO has partnered with CityLife Neighborhood Clinics/Ampersand Health, LLC to create a Patient Centered Medical Home (PCMH) within TEI’s Philadelphia clinic. Occupying a space of approximately 8,100 square feet, the University was approved for a $1 million grant from the Redevelopment Assistance Capital Program of the Commonwealth of Pennsylvania. The […]

National Academies of Practice Inducts Distinguished Practitioners  Fellows

National Academies of Practice Inducts Distinguished Practitioners Fellows

The National Academies of Practice (NAP) inducted several Distinguished Practitioners & Fellows of NAP during a gala banquet on March 18, 2017 in Philadelphia, PA. They are pictured above top from left to right: Dr. William L. Jones;  Dr. Donald Egan (KYCO); Dr. Jeffrey A. Myers; Dr. Brett Bence. Bottom left to right: Dr. Gregory […]

Dr. Jingyun Wang of Salus University Receives AOF Johnson & Johnson Vision Care, Inc. Innovation in Education Grant

Dr. Jingyun Wang of Salus University Receives AOF Johnson & Johnson Vision Care, Inc. Innovation in Education Grant

Dr. Jingyun Wang, PhD, assistant professor at the Salus University Pennsylvania College of Optometry (PCO), has been awarded the University’s first-ever Innovation in Education grant from The American Optometric Foundation (AOF) in collaboration with Johnson & Johnson Vision Care, Inc. The grant is designed to aid recently appointed faculty in advancing their teaching skills in […]

SUNY College of Optometry Earns AAHRPP Accreditation

SUNY College of Optometry Earns AAHRPP Accreditation

The Association for the Accreditation of Human Research Protection Programs (AAHRPP) accredited SUNY College of Optometry’s human subject research program on Wednesday, March 22. AAHRPP provides accreditation for organizations that conduct or review human research, demonstrate that they have built extensive safeguards into every level of their research operation, and adhere to high standards for […]

Meet CooperVision’s 2017 Best Practices Honorees

Meet CooperVision’s 2017 Best Practices Honorees

New Class Chosen for Their Leadership and Success in Optometry From small practices to large practices. From a broad array of services to the specialized. From “tried and true” to the completely unexpected. Despite their differences, 10 remarkable US eye care practices have much in common. They have forged new pathways to success in the […]

CooperVision Begins Rollout of Avaira Vitality™ toric

CooperVision Begins Rollout of Avaira Vitality™ toric

State-of-the-Art Silicone Hydrogel Material Provides High Oxygen Transmissibility to Wearers with Astigmatism. The latest advancements in two-week contact lens technology are now available to eye care professionals and their astigmatic patients, as CooperVision, Inc. announced today the beginning of its limited rollout of Avaira Vitality™ toric. The lens is the latest addition to the new […]

LensFerry® S Expands to Include All Contact Lens Modalities

LensFerry® S Expands to Include All Contact Lens Modalities

Doctor-Friendly Subscription Service Promotes Increased Annual Supply Sales for Practices and Convenience for WearersEyeCare Prime® announced that LensFerry® S has expanded to include all modalities, bringing the convenience of automatic monthly payments and quarterly or semi-annual contact lens deliveries to a broader spectrum of patients while maintaining a central role for the eye care professional. The […]

Bausch + Lomb And Nicox Announce PDUFA Date For Novel Glaucoma Candidate Latanoprostene Bunod

Bausch + Lomb And Nicox Announce PDUFA Date For Novel Glaucoma Candidate Latanoprostene Bunod

Valeant Pharmaceuticals International, Inc.’s (NYSE: VRX and TSX: VRX) wholly owned subsidiary, Bausch + Lomb, and Nicox S.A. (Euronext Paris: FR0013018124, COX) announced that the US Food and Drug Administration (FDA) has set a PDUFA date of August 24, 2017 for its decision on the New Drug Application (NDA) for latanoprostene bunod ophthalmic solution, 0.024%. Latanoprostene […]

Bausch + Lomb Introduces Biotrue® ONEday for Astigmatism Contact Lenses

Bausch + Lomb Introduces Biotrue® ONEday for Astigmatism Contact Lenses

New Innovative Daily Disposable Lens Designed to Provide Astigmatic Patients Consistently Clear Vision and Comfort Throughout the Day. Baush + Lomb, a leading global eye health company, announced the introduction of Biotrue® ONEday for Astigmatism daily disposable contact lenses. Approximately 73.2 million people in the US are astigmatic, but only 8. million people are currently […]